Therefore, the elevated PSA levels in the prostate of patients with BPH during their COVID-19 infection period confirmed the deleterious effect of SARS-CoV-2 on these tissues through pro-inflammatory pathways triggered by the suppression of anti-inflammatory ACE2 and the upregulation of Ang II [21]. Here, PROS1 is linked to benign prostatic hyperplasia.